SPARC.BO
Sun Pharma Advanced Research Company Limited$237.70
-1.80%Jun 19, 2026
Market cap
$78.85B
52w range
—
P / E
—
EPS · FY 2026
$47.86
Volume
—
Revenue · FY 2026
$18.79B
Explain this page
Arphra AIPlain-English read on Sun Pharma Advanced Research Company Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,106.02
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →SPARC.BO
237.70+51.21%H 252.95L 108.20MA50 180.43MA200 145.03Avg vol 247K
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Consumer Cyclical+1.37%
- Technology+1.17%
- Utilities+0.96%
- Financial Services+0.65%
- Basic Materials+0.59%
- Industrials+0.54%
- Consumer Defensive+0.42%
- Energy-0.18%
- Communication Services-0.40%
- Healthcare-0.41%
- Real Estate-0.54%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic+1.29%
- Biotechnology+9.63%
- Software - Services-7.11%
- Business Equipment & Supplies+6.51%
- Financial - Mortgages+4.52%
- Furnishings, Fixtures & Appliances+4.34%
- Home Improvement+3.89%
- Construction+3.62%
- Paper, Lumber & Forest Products+3.53%
- Discount Stores+3.53%
- Medical - Diagnostics & Research+3.31%
- Financial - Conglomerates+3.03%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for SPARC.BO.
Financial scores
DBJun 20, 2026Altman Z
8.09
Safe
≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress
Piotroski F
6/9
Average
≥ 7 strong · 4–6 average · < 4 weak
Peers
No peer list available for SPARC.BO.
Total assets
$21.71B
Total debt
$5.59B
Cash & equiv
$11.6M
Operating CF
-$2.73B
Free cash flow
-$2.97B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $18.79B | $15.89B | $15.53B | $47.86 | +82.65% |